CN114010745A - 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 - Google Patents
治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 Download PDFInfo
- Publication number
- CN114010745A CN114010745A CN202111322190.5A CN202111322190A CN114010745A CN 114010745 A CN114010745 A CN 114010745A CN 202111322190 A CN202111322190 A CN 202111322190A CN 114010745 A CN114010745 A CN 114010745A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- medicine composition
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 208000014674 injury Diseases 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 36
- 208000020084 Bone disease Diseases 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- 238000000034 method Methods 0.000 title claims abstract description 15
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 19
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 19
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 19
- 241001673966 Magnolia officinalis Species 0.000 claims abstract description 19
- 241000489492 Arisaema Species 0.000 claims abstract description 17
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 17
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 16
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 15
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 15
- 235000013976 turmeric Nutrition 0.000 claims abstract description 15
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 14
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 14
- 235000005155 Tanacetum balsamita Nutrition 0.000 claims abstract description 14
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 13
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 241000427159 Achyranthes Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001369613 Stephania tetrandra Species 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 21
- 239000000047 product Substances 0.000 claims description 17
- 208000025747 Rheumatic disease Diseases 0.000 claims description 14
- 230000000552 rheumatic effect Effects 0.000 claims description 14
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 13
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 13
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims description 12
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 11
- 235000011477 liquorice Nutrition 0.000 claims description 11
- 241000382455 Angelica sinensis Species 0.000 claims description 9
- 238000001035 drying Methods 0.000 claims description 8
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 244000061520 Angelica archangelica Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 4
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 3
- 235000014375 Curcuma Nutrition 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 3
- 108010000912 Egg Proteins Proteins 0.000 claims description 3
- 235000014103 egg white Nutrition 0.000 claims description 3
- 210000000969 egg white Anatomy 0.000 claims description 3
- 241000331983 Arisaema consanguineum Species 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 241000304195 Salvia miltiorrhiza Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 36
- 208000002193 Pain Diseases 0.000 abstract description 22
- 230000036407 pain Effects 0.000 abstract description 22
- 230000017531 blood circulation Effects 0.000 abstract description 13
- 230000001737 promoting effect Effects 0.000 abstract description 13
- 244000132619 red sage Species 0.000 abstract description 11
- 230000008961 swelling Effects 0.000 abstract description 9
- 210000003205 muscle Anatomy 0.000 abstract description 6
- 210000002435 tendon Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 4
- 210000003127 knee Anatomy 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 230000002829 reductive effect Effects 0.000 abstract description 3
- 230000002040 relaxant effect Effects 0.000 abstract description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract description 2
- 230000000857 drug effect Effects 0.000 abstract description 2
- 230000002349 favourable effect Effects 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 201000004595 synovitis Diseases 0.000 abstract description 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 13
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 13
- 210000004185 liver Anatomy 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 10
- 235000012754 curcumin Nutrition 0.000 description 9
- 239000004148 curcumin Substances 0.000 description 9
- 229940109262 curcumin Drugs 0.000 description 9
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 9
- 239000000341 volatile oil Substances 0.000 description 9
- 206010042674 Swelling Diseases 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- 208000005171 Dysmenorrhea Diseases 0.000 description 5
- 206010013935 Dysmenorrhoea Diseases 0.000 description 5
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical group O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 208000006673 asthma Diseases 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 4
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 4
- 229940117916 cinnamic aldehyde Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 229930013686 lignan Natural products 0.000 description 4
- 235000009408 lignans Nutrition 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- KINGXFAMZNIVNL-SXQDSXCISA-N safflor yellow A Natural products OC[C@@H]1O[C@H]2[C@H](OC3=C2C(=O)C(=C(O)C=Cc4ccc(O)cc4)C(=O)[C@]3(O)[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@@H](O)[C@H]1O KINGXFAMZNIVNL-SXQDSXCISA-N 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 229930189533 tanshinol Natural products 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 3
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 3
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 3
- 206010061876 Obstruction Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 3
- 229940116229 borneol Drugs 0.000 description 3
- 229960005233 cineole Drugs 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 150000005692 lignans Chemical class 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 235000019633 pungent taste Nutrition 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- CEHVTERMWMYLCP-UHFFFAOYSA-N 1-(hydroxymethyl)-6,6-dimethyl-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound C1=2OC=C(CO)C=2C(=O)C(=O)C2=C1C=CC1=C2CCCC1(C)C CEHVTERMWMYLCP-UHFFFAOYSA-N 0.000 description 2
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 2
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 240000000031 Achyranthes bidentata Species 0.000 description 2
- 241000219317 Amaranthaceae Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- DYQVDISPPLTLLR-HJQYTNQXSA-N Carthamin Natural products CC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)[C@]2(O)C(=C(C=C/3C(=O)C(=C(O)[C@](O)([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C3=O)C(=O)C=Cc5ccc(O)cc5)C(=O)C(=C2O)C(=O)C=Cc6ccc(O)cc6)O DYQVDISPPLTLLR-HJQYTNQXSA-N 0.000 description 2
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 2
- 241000514824 Cyathula officinalis Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- UPCWCCRFMPIOAP-UHFFFAOYSA-N Hydroxytanshinone Chemical compound C1=CC(C(CCC2O)(C)C)=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 UPCWCCRFMPIOAP-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000218377 Magnoliaceae Species 0.000 description 2
- 241000218164 Menispermaceae Species 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 240000007164 Salvia officinalis Species 0.000 description 2
- 229930183118 Tanshinone Natural products 0.000 description 2
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 2
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 2
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 2
- 235000012665 annatto Nutrition 0.000 description 2
- 230000002082 anti-convulsion Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- IIQSJHUEZBTSAT-VMPREFPWSA-N fangchinoline Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-VMPREFPWSA-N 0.000 description 2
- IIQSJHUEZBTSAT-UHFFFAOYSA-N fangchinoline Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(O)C1=C23 IIQSJHUEZBTSAT-UHFFFAOYSA-N 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- -1 monoterpene lignans Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 230000001020 rhythmical effect Effects 0.000 description 2
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- HUJXHFRXWWGYQH-UHFFFAOYSA-O sinapine Chemical compound COC1=CC(\C=C\C(=O)OCC[N+](C)(C)C)=CC(OC)=C1O HUJXHFRXWWGYQH-UHFFFAOYSA-O 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- GRWFGVWFFZKLTI-UHFFFAOYSA-N α-pinene Chemical compound CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 2
- NPNUFJAVOOONJE-ZIAGYGMSSA-N β-(E)-Caryophyllene Chemical compound C1CC(C)=CCCC(=C)[C@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-ZIAGYGMSSA-N 0.000 description 2
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- UEPVWRDHSPMIAZ-IZTHOABVSA-N (1e,4z,6e)-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)hepta-1,4,6-trien-3-one Chemical compound C1=C(O)C(OC)=CC(\C=C\C(\O)=C\C(=O)\C=C\C=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-IZTHOABVSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CETREAVXUDHZGK-UHFFFAOYSA-N 1-(hydroxymethyl)-6-methylnaphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound C12=CC=C3C(C)=CC=CC3=C2C(=O)C(=O)C2=C1OC=C2CO CETREAVXUDHZGK-UHFFFAOYSA-N 0.000 description 1
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- GRWFGVWFFZKLTI-IUCAKERBSA-N 1S,5S-(-)-alpha-Pinene Natural products CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- KMTDMTZBNYGUNX-UHFFFAOYSA-N 4-methylbenzyl alcohol Chemical compound CC1=CC=C(CO)C=C1 KMTDMTZBNYGUNX-UHFFFAOYSA-N 0.000 description 1
- ROPDWYIWHWKVLI-UHFFFAOYSA-N 4-prop-2-enyl-2-(4-prop-2-enylphenoxy)phenol Chemical compound OC1=CC=C(CC=C)C=C1OC1=CC=C(CC=C)C=C1 ROPDWYIWHWKVLI-UHFFFAOYSA-N 0.000 description 1
- HVDFMKSCPKILEQ-UHFFFAOYSA-N 5-methoxy-2,3-dimethylphenol Chemical compound COC1=CC(C)=C(C)C(O)=C1 HVDFMKSCPKILEQ-UHFFFAOYSA-N 0.000 description 1
- NVEQFIOZRFFVFW-UHFFFAOYSA-N 9-epi-beta-caryophyllene oxide Natural products C=C1CCC2OC2(C)CCC2C(C)(C)CC21 NVEQFIOZRFFVFW-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 235000003840 Amygdalus nana Nutrition 0.000 description 1
- 235000011446 Amygdalus persica Nutrition 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 241000209524 Araceae Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DFOCUWZXJBAUSQ-URLMMPGGSA-N Berbamine Chemical compound C([C@@H]1N(C)CCC=2C=C(C(OC=3C(OC)=C(OC)C=C4CCN(C)[C@@H](C=34)CC=3C=C(C(=CC=3)O)O3)=CC=21)OC)C1=CC=C3C=C1 DFOCUWZXJBAUSQ-URLMMPGGSA-N 0.000 description 1
- DFOCUWZXJBAUSQ-UHFFFAOYSA-N Berbamine Natural products O1C(C(=CC=2)O)=CC=2CC(C=23)N(C)CCC3=CC(OC)=C(OC)C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C1C=C2 DFOCUWZXJBAUSQ-UHFFFAOYSA-N 0.000 description 1
- 244000017106 Bixa orellana Species 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010048962 Brain oedema Diseases 0.000 description 1
- 241000208809 Carthamus Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- GVKKJJOMQCNPGB-JTQLQIEISA-N Cryptotanshinone Chemical compound O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1[C@@H](C)CO2 GVKKJJOMQCNPGB-JTQLQIEISA-N 0.000 description 1
- GVKKJJOMQCNPGB-UHFFFAOYSA-N Cryptotanshinone Natural products O=C1C(=O)C2=C3CCCC(C)(C)C3=CC=C2C2=C1C(C)CO2 GVKKJJOMQCNPGB-UHFFFAOYSA-N 0.000 description 1
- QRMPRVXWPCLVNI-UHFFFAOYSA-N Curcumenol Natural products C1C(=C)C2CCC(C)C22CC(C(C)C)C1(O)O2 QRMPRVXWPCLVNI-UHFFFAOYSA-N 0.000 description 1
- HJTVQHVGMGKONQ-LUZURFALSA-N Curcumin II Natural products C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=CC(O)=CC=2)=C1 HJTVQHVGMGKONQ-LUZURFALSA-N 0.000 description 1
- 241000241550 Cyathula Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- BYTORXDZJWWIKR-UHFFFAOYSA-N Hinokiol Natural products CC(C)c1cc2CCC3C(C)(CO)C(O)CCC3(C)c2cc1O BYTORXDZJWWIKR-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010050296 Intervertebral disc protrusion Diseases 0.000 description 1
- SNYVPSXUTGEODU-UHFFFAOYSA-N Isomagnolol Natural products OC1=CC=C(CC=C)C=C1OC1=CC=CC(CC=C)=C1 SNYVPSXUTGEODU-UHFFFAOYSA-N 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- NEEQFPMRODQIKX-REOHCLBHSA-N N(3)-oxalyl-L-2,3-diaminopropionic acid Chemical group OC(=O)[C@@H](N)CNC(=O)C(O)=O NEEQFPMRODQIKX-REOHCLBHSA-N 0.000 description 1
- YYSRTHIUABRSAB-UHFFFAOYSA-N Neocarthamin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C(O)C2=C1C(=O)CC(C=1C=CC(O)=CC=1)O2 YYSRTHIUABRSAB-UHFFFAOYSA-N 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- ZVKOASAVGLETCT-UOGKPENDSA-N Norbixin Chemical compound OC(=O)/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(O)=O ZVKOASAVGLETCT-UOGKPENDSA-N 0.000 description 1
- JERYLJRGLVHIEW-UENHKZIGSA-N Norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=CC=CC(=O)O JERYLJRGLVHIEW-UENHKZIGSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010034238 Pelvic adhesions Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 241000220299 Prunus Species 0.000 description 1
- 235000011432 Prunus Nutrition 0.000 description 1
- 240000002381 Prunus davidiana Species 0.000 description 1
- 235000015533 Prunus davidiana Nutrition 0.000 description 1
- SVCXTVVQYVKZTG-SNVBAGLBSA-N Przewaquinone B Natural products Cc1cccc2c3C(=O)C(=O)C4=C(OC[C@H]4CO)c3ccc12 SVCXTVVQYVKZTG-SNVBAGLBSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 229930194268 Salvianic acid Natural products 0.000 description 1
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 201000010001 Silicosis Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241001300193 Speranskia Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001330502 Stephania Species 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- ZVKOASAVGLETCT-UOAMSCJGSA-N all-trans norbixin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C(=O)O)C=CC=C(/C)C=CC(=O)O ZVKOASAVGLETCT-UOAMSCJGSA-N 0.000 description 1
- FAMPSKZZVDUYOS-UHFFFAOYSA-N alpha-Caryophyllene Natural products CC1=CCC(C)(C)C=CCC(C)=CCC1 FAMPSKZZVDUYOS-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 239000001670 anatto Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000010362 annatto Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000001266 bandaging Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FDABVSXGAMFQQH-XZWHSSHBSA-N berbamunine Chemical compound CN1CCC2=CC(OC)=C(O)C=C2[C@H]1CC1=CC=C(O)C(OC2=CC=C(C=C2)C[C@@H]2N(C)CCC=3C=C(C(=CC=32)O)OC)=C1 FDABVSXGAMFQQH-XZWHSSHBSA-N 0.000 description 1
- NPNUFJAVOOONJE-UHFFFAOYSA-N beta-cariophyllene Natural products C1CC(C)=CCCC(=C)C2CC(C)(C)C21 NPNUFJAVOOONJE-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000006752 brain edema Diseases 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- NPNUFJAVOOONJE-UONOGXRCSA-N caryophyllene Natural products C1CC(C)=CCCC(=C)[C@@H]2CC(C)(C)[C@@H]21 NPNUFJAVOOONJE-UONOGXRCSA-N 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- ISFMXVMWEWLJGJ-NZBPQXDJSA-N curcumenol Chemical compound CC1=C[C@](O2)(O)C(=C(C)C)C[C@@]22[C@@H](C)CC[C@H]21 ISFMXVMWEWLJGJ-NZBPQXDJSA-N 0.000 description 1
- ZVMJXSJCBLRAPD-UHFFFAOYSA-N curzerenone Chemical compound C1C(C=C)(C)C(C(=C)C)C(=O)C2=C1OC=C2C ZVMJXSJCBLRAPD-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- NMRUIRRIQNAQEB-UHFFFAOYSA-N demethoxycurcumin Natural products OC(=CC(C=CC1=CC(=C(C=C1)O)OC)=O)C=CC1=CC=C(C=C1)O NMRUIRRIQNAQEB-UHFFFAOYSA-N 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- FVYXIJYOAGAUQK-UHFFFAOYSA-N honokiol Chemical compound C1=C(CC=C)C(O)=CC=C1C1=CC(CC=C)=CC=C1O FVYXIJYOAGAUQK-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- UBFTZAGDGOMJQE-SACPXRHSSA-N neocarthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(O)C(O)=CC2=C1C(=O)C[C@@H](C=1C=CC(O)=CC=1)O2 UBFTZAGDGOMJQE-SACPXRHSSA-N 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000005830 nonesterified fatty acids Chemical class 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- UEPVWRDHSPMIAZ-UHFFFAOYSA-N p-hydroxycinnamoyl feruloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(O)=CC(=O)C=CC=2C=CC(O)=CC=2)=C1 UEPVWRDHSPMIAZ-UHFFFAOYSA-N 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 229960003371 protocatechualdehyde Drugs 0.000 description 1
- 235000014774 prunus Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229930006696 sabinene Natural products 0.000 description 1
- 229930194301 safflor yellow Natural products 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- KOWMJRJXZMEZLD-UHFFFAOYSA-N syringaresinol Chemical compound COC1=C(O)C(OC)=CC(C2C3C(C(OC3)C=3C=C(OC)C(O)=C(OC)C=3)CO2)=C1 KOWMJRJXZMEZLD-UHFFFAOYSA-N 0.000 description 1
- LVUPFEOCDSHRBL-UHFFFAOYSA-N syringaresinol Natural products COc1cccc(OC)c1C2OCC3C2COC3c4c(OC)cccc4OC LVUPFEOCDSHRBL-UHFFFAOYSA-N 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- VLRNWUFGTCSJDO-UHFFFAOYSA-N trans-Isomagnolol Natural products CC=CC1=CC=C(O)C(C=2C(=CC=C(C=CC)C=2)O)=C1 VLRNWUFGTCSJDO-UHFFFAOYSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于中药材技术领域,公开了一种治疗风湿骨病跌打损伤的中药组合物、制备和使用方法。该组合物是由透骨草、红花、桃仁、制南星、厚朴、姜黄、桂枝、防己、当归、三七、牛膝、丹参和甘草混合制备而成。该方剂适用于治疗风湿骨病跌打损伤、滑膜炎和膝盖痹症等。具有除湿利水、消肿止痛、舒筋活血的功效。上述该中药组合物的制备方法简单便捷,在对原料减少处理过程中,可以减少对原料中有效成分的损失,提高有效成分的含有量,进而提高使用药效。本方剂为外用方剂,制备成粉剂成品,不仅有利于保存,且在后续实际使用时直接调和水即可获得膏药进行使用,便捷性极高,具有安全性,无任何毒副作用和刺激性。
Description
技术领域
本发明属于中药材技术领域,具体涉及一种治疗风湿骨病跌打损伤的中药组合物、制备和使用方法。
背景技术
风湿骨病在西医上称为风湿热、风湿性关节炎、类风湿性关节炎、腰椎间盘突出、骨质增生等症,以关节疼痛、酸困、麻木、活动受限、僵硬变形为主要临床表现,严重的卧床不起,疼痛难忍,生活不能自理。祖国医学认为此症属于“痹症”的范围。诱发本病的因素是因为人体肝、脾、肾精血不足,筋骨失养,自然界中风、寒、湿、热之邪侵入人体,进入关节,使气血痹阻,引起气血运行不畅,造成经络不通或痰浊瘀血。或劳逸外伤致使瘀血停滞、经脉不通,引起关节疼痛,肢体麻木,关节僵硬,屈身不利等症状。
在目前现有的技术中,西医治疗本病常以消炎止痛、激素、牵引、手术或是包扎等方法。其缺点是治标不治本,治疗时间长,疗效差,费用大,且手术危险性极高,同时患者具有长期痛苦。中医采用内服中药,以舒筋活络、活血化瘀等方法,效果不明显,或者初服有效随后则无作用,疗效不持久,复发率高。而且内服中药不方便,有的中药对胃有刺激,产生不良的副作用。
发明内容
为了解决现有技术存在的上述问题,本发明目的在于提供一种治疗风湿骨病跌打损伤的中药组合物、制备和使用方法。
本发明所采用的技术方案为:一种治疗风湿骨病跌打损伤的中药组合物,所述组合物主要由以下质量份数的原料制备得到:
透骨草30-50份,红花10-20份,桃仁25-60份,制南星10-25份,厚朴5-20份,姜黄30-50份,桂枝15-35份,防己8-30份,当归20-55份,三七50-70份,牛膝5-18份,丹参30-50份和甘草6-25份。
透骨草,中药名。为大戟科地构叶属植物地构叶Speranskiatuberculata(Bunge)Baill.的全草。植物地构叶,分布于我国辽宁、吉林、内蒙古、河北、河南、山西、陕西、甘肃、山东、江苏、安徽、四川。具有祛风除湿,舒筋活血,散瘀消肿,解毒止痛之功效。主治风湿痹痛,筋骨挛缩,寒湿脚气,腰部扭伤,瘫痪,闭经,阴囊湿疹,疮疖肿毒。味辛,性温。入肝、肾经。
红花,中药名。为菊科红花属植物红花Carthamus tinctorius L.的干燥花。具有活血通经,祛瘀止痛的功效。主治血滞经闭、痛经,产后瘀滞腹痛,癥瘕积聚,胸痹心痛,血瘀腹痛,胁痛,跌打损伤,瘀滞肿痛,瘀滞斑疹色暗。味辛,性温;归心、肝经。化学成分:含有红花醌苷、新红花苷、红花苷、红花黄色素和黄色素。另含红花油,油中包括棕榈酸、肉豆蔻酸、月桂酸、硬脂酸、花生酸、油酸等。药理作用:1、对心血管系统的影响:红花轻度兴奋心脏、降低冠脉阻力,增加冠脉流量和心肌营养性血流量,保护和改善心肌缺血,缩小心肌梗死范围;红花黄色素分离物能对抗心律失常;煎剂、水提液、红花黄色素等能扩张周围血管、降低血压。2、对血液流变学的影响:红花能抗凝血,抗血栓形成,降低全血黏度,降低红细胞的聚集性,维持血液黏度的正常。3、对神经系统的影响:红花黄色素对中枢神经系统有镇痛、镇静和抗惊厥作用。注射液、醇提物、红花苷能显著提高耐缺氧能力,减少缺血性脑水肿,对实验性脑梗死动物的组织有保护作用。4、对肝胆系统的影响:红花能降低谷丙转氨酶,改善肝功能。5、对代谢系统的影响:红花能降低血清总胆固醇、三硝酸甘油脂和非酯化脂肪酸水平。6、对生殖器官的影响:红花煎剂对子宫和肠道平滑肌有兴奋作用,抗盆腔粘连。此外,红花醇提物和水提物有抗炎作用,红花黄色素有免疫抑制作用。
桃仁,中药名。为蔷薇科桃属植物桃Prunus persica(L.)Batsch或山桃Prunusdavidiana(Carr.)Franch.的干燥成熟种子。果实成熟后采收,除去果肉和核壳,取出种子,晒干。全国各地普遍栽培。具有活血祛瘀,润肠通便,止咳平喘的功效。主治经闭痛经,瘕瘕痞块,肺痈肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。味苦、甘,性平;归心、肝、大肠经。含苦杏仁苷、苦杏仁酶、挥发油、脂肪油(油酸甘油酯、亚油酸甘油酯)等。
制南星,为草本植物,属天南星科。药用部分是它的块茎。南星味苦辛,性温,人肺、肝、脾经,功能燥湿化痰,祛风定惊,消痞散结,消肿镇痛。南星临床上常用品有生南星、制南星及胆南星3种。生南星有毒,临床多外用,具有良好的消肿止痛作用。
厚朴,中药名。为木兰科木兰属植物厚朴Magnolia officinalis Rehd.et Wils.或凹叶厚朴Magnolia offinalis Rehd.et Wils.var.biloba Rehd.et Wils.的干燥干皮、根皮及枝皮。具有燥湿消痰,下气除满的功效。主治湿阻中焦、脘腹胀满,食积气滞、腹胀便秘,肺气不降、痰饮喘咳,湿浊不分、霍乱泄泻,七情郁结、痰气互阻之梅核气等。味苦、辛,性温;归脾、胃、肺、大肠经。化学成分:主要含木脂素、生物碱及挥发油。木脂素中的主要成分为厚朴酚、四氢厚朴酚、异厚朴酚、和厚朴酚及丁香脂素与厚朴醛;去甲木脂素中主要分离出厚朴三醇和厚朴醛;单萜木脂素中已分离出辣薄荷厚朴酚及龙脑基厚朴酚。厚朴挥发油是厚朴的主要化学成分之一,约为1%。其中以桉醇为主,尚含有桉叶醇、烯类、酯类、烷类和其他醇类。厚朴中的生物碱主要为木兰箭毒碱、芥子醛等。
姜黄,中药名。为姜科姜黄属植物姜黄Curcuma longa L.的干燥根茎。具有活血行气,通经止痛的功效。主治气滞血瘀痛证,风湿痹痛。味辛、苦,性寒;归肝、胆、心经。化学成分:含有挥发油,主要成分为姜黄酮、芳姜黄酮、姜烯、水芹烯、香桧烯、桉油素、莪术酮、莪术醇、丁香烯龙脑、樟脑等;色素物,主要为姜黄素、去甲氧基姜黄素;以及胭脂树橙和降胭脂树素和微量元素等。药理作用:姜黄素能抑制血小板聚集,降低血浆黏度和全血黏度;水煎剂、姜黄粉石油醚、乙醇和水提物有抗早孕作用;姜黄素、水提物及有效成分有抗肿瘤作用;姜黄素、醇或醚提取物和挥发油能降血脂;姜黄素又有抗炎作用;姜黄素对细菌有抑制作用,而挥发油则对真菌有强力的抑制作用;姜黄提取物、姜黄素、挥发油、姜黄酮以及姜烯、龙脑和倍半萜烯等都能利胆;姜黄素有短而强烈的降压作用,对离体豚鼠心脏有抑制作用;姜黄素能保护胃黏膜,保护肝细胞。
桂枝,中药名。为樟科樟胡椒属植物肉桂Cinnamomum cassia Presl的嫩枝。具有发汗解肌,温通经脉,助阳化气的功效。主治风寒感冒,寒凝血滞诸痛症,痰饮,蓄水证,心悸。味辛、甘,性温;归心、肺、膀胱经。化学成分本品含挥发油,其主要成分为桂皮醛等。另外尚含有酚类、有机酸、多糖、苷类、香豆精及鞣质等。药理作用桂枝水煎剂及桂皮醛有降温、解热作用。桂枝煎剂及乙醇浸液对金黄色葡萄球菌、白色葡萄球菌、伤寒杆菌、常见致病皮肤真菌、痢疾杆菌、肠炎沙门氏菌、霍乱弧菌、流感病毒等均有抑制作用。桂皮油、桂皮醛对结核杆菌有抑制作用,桂皮油有健胃、缓解胃肠道痉挛及利尿、强心等作用。桂皮醛有镇痛、镇静、抗惊厥作用。挥发油有止咳、祛痰作用。
防己,中药名。为防己科千金藤属植物粉防己Stephania tetrandra S.Moore的干燥根。习称“汉防己”。具有祛风湿,止痛,利水消肿的功效。主治风湿痹证,水肿,小便不利,脚气,湿疹疮毒。味苦、辛,性寒;归膀胱、肺经。化学成分:汉防己(粉防己)含粉防己碱(即汉防己甲素),防己诺灵碱,轮环藤酚碱,氧防己碱,防己斯任碱,小檗胺,2,2’-N,N-二氯甲基粉防己碱,粉防己碱A、B、C、D。药理作用:粉防己能明显增加排尿量。总碱及流浸膏或煎剂有镇痛作用。粉防己碱有抗炎作用;对心肌有保护作用,能扩张冠状血管,增加冠脉流量,有显著降压作用,能对抗心律失常;能明显抑制血小板聚集,还能促进纤维蛋白溶解,抑制凝血酶引起的血液凝固过程;对实验性矽肺有预防治疗作用;对子宫收缩有明显的松弛作用;低浓度的粉防己碱可使肠张力增加,节律性收缩加强,高浓度则降低张力、减弱节律性收缩;有抗菌和抗阿米巴原虫的作用;可使正常大鼠血糖明显降低,血清胰岛素明显升高;有一定抗肿瘤作用;对免疫有抑制作用;有广泛的抗过敏作用。
当归,中药名。为伞形科当归属植物当归Angelica sinensis(Oliv)Diels.的根。具有补血调经,活血止痛,润肠通便的功效。主治血虚萎黄,月经不调,经闭痛经,血虚、血滞、血寒诸痛,跌打损伤,风湿痹痛,痈疽疮疡,肠燥便秘等。味甘、辛,性温;归肝、心、脾经。化学成分:当归中含β-蒎烯、α-蒎烯、莰烯等中性油成分。含对-甲基苯甲醇、5-甲氧基-2,3-二甲苯酚等酸性油成分、有机酸、糖类、维生素、氨基酸等。
三七,中药名。为五加科人参属植物三七Panax notoginseng(Burk.)F.H.Chen的干燥根。具有化瘀止血,活血定痛的功效。主治各种出血证,瘀血肿痛、跌打损伤等属于瘀血阻滞者。味甘、微苦,性温;归肝、胃经。化学成分:本品主要含皂苷、黄酮苷、氨基酸等。止血活性成分为三七氨酸。
牛膝,中药名。为苋科牛膝属植物牛膝(怀牛膝)Achyranthes bidentata BI.和川牛膝属(杯苋属)植物川牛膝(甜牛膝)Cyathula officinalis Kuan的根。具有活血通经,补肝肾,强筋骨,利水通淋,引火(血)下行的功效。主治瘀血阻滞经闭、痛经、经行腹痛、胞衣不下,跌打伤痛,腰膝酸痛,下肢痿软,淋证,水肿,小便不利,头痛,眩晕,齿痛,口舌生疮,吐血,衄血。味苦、甘、酸,性平;归肝、肾经。化学成分:牛膝含有三萜皂苷(经水解后成为齐墩果酸和糖)、蜕皮甾酮、牛膝甾酮、紫茎牛膝甾酮等甾体类成分和多糖类成分。此外,牛膝还含有精氨酸等12种氨基酸以及生物碱类、香豆素类等化合物和铁、铜等微量元素。
丹参,中药名。为唇形科鼠尾草属植物丹参Salvia miltiorrhiza Bge.的干燥根和根茎。具有活血调经,祛瘀止痛,凉血消痈,除烦安神的功效。主治月经不调,闭经痛经,产后瘀滞腹痛,血瘀心痛,脘腹疼痛,癥瘕积聚,跌打损伤,风湿痹证,疮痈肿毒,热病烦躁神昏,心悸失眠。味苦,性微寒;归心、心包、肝经。化学成分:主含脂溶性成分和水溶性成分。脂溶性成分包括丹参酮Ⅰ、丹参酮ⅡA、丹参酮ⅡB、丹参酮Ⅲ、隐丹参酮、羟基丹参酮、丹参酸甲酯、紫丹参甲素、紫丹参乙素、丹参新酮、丹参醇I、丹参醇Ⅱ、丹参醇Ⅲ、丹参酚、丹参醛等。水溶性成分主要含有丹参素,丹参酸甲、乙、丙,原儿茶酸、原儿茶醛等。
甘草,中药名。为豆科甘草属植物植物甘草Glycyrrhiza uralensis Fisch.、胀果甘草Glycyrrhiza inflata Bat.或光果甘草Glycyrrhiza glabra L.的干燥根和根茎。具有益气补中,润肺止咳,清热解毒,缓急止痛,调和药性的功效。主治脾虚倦怠,心虚悸动,咳嗽气喘,痈疽喉痹,药食中毒,脘腹、四肢挛急疼痛等。味甘,性平;归心、肺、脾经。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
透骨草35-45份,红花12-18份,桃仁30-52份,制南星15-23份,厚朴10-18份,姜黄35-45份,桂枝20-30份,防己12-25份,当归30-40份,三七55-62份,牛膝8-15份,丹参35-45份和甘草10-20份。
作为优选地,所述组合物主要由以下质量份数的原料制备得到:
透骨草40份,红花16份,桃仁48份,制南星20份,厚朴15份,姜黄40份,桂枝25份,防己20份,当归35份,三七60份,牛膝12份,丹参40份和甘草15份。
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草、红花、桃仁、制南星、厚朴、姜黄、桂枝、防己、当归、三七、牛膝、丹参和甘草混合、经干燥、研磨、过筛后,获得成品。
作为优选地,所述成品为外用制剂。
作为优选地,所述干燥温度为40-45摄氏度。
作为优选地,所述干燥时长为20-35分钟。
作为优选地,所述过800-1500目滤筛。
一种治疗风湿骨病跌打损伤的中药组合物的使用方法,采用权利要求1-3任一所述的疗风湿骨病跌打损伤的中药组合物或者采用权利要求4-8任一所述的风湿骨病跌打损伤的中药组合物的制备方法获得的成品,使用时,加入溶剂调配混匀,涂覆在患处皮肤处。
作为优选地,所述溶剂为水、鸡蛋清和白酒中的任意一种;
所述溶剂与成品调配比例为0.3-0.6:1wt%。
本发明的有益效果为:
本发明提供了一种治疗风湿骨病跌打损伤的中药组合物,该组合物是由透骨草、红花、桃仁、制南星、厚朴、姜黄、桂枝、防己、当归、三七、牛膝、丹参和甘草混合制备而成。该方剂适用于治疗风湿骨病跌打损伤、滑膜炎和膝盖痹症等。具有除湿利水、消肿止痛、舒筋活血的功效。
上述该中药组合物的制备方法简单便捷,在对原料减少处理过程中,可以减少对原料中有效成分的损失,提高有效成分的含有量,进而提高使用药效。
本方剂为外用方剂,制备成粉剂成品,不仅有利于保存,且在后续实际使用时用溶剂直接调和即可获得膏药进行使用,便捷性极高,具有安全性,无任何毒副作用和刺激性。
具体实施方式
下面结合具体实施例对本发明做进一步阐释。本领域技术人员将会理解,下列所描述的实施例是本发明一部分实施例,而不是全部的实施例,仅用于说明本发明,而不应视为限制本发明的范围。所用试剂均为可以通过市售购买获得的常规产品。
实施例1:
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草300克、红花100克、桃仁250克、制南星100克、厚朴50克、姜黄300克、桂枝150克、防己80克、当归200克、三七500克、牛膝50克、丹参300克和甘草60克混合、在40摄氏度下干燥20分钟、研磨、过800目滤筛后,获得成品制剂。
实施例2:
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草500克、红花200克、桃仁600克、制南星250克、厚朴200克、姜黄500克、桂枝350克、防己300克、当归550克、三七700克、牛膝180克、丹参500克和甘草250克混合、在45摄氏度下干燥20分钟、研磨、过1500目滤筛后,获得成品制剂。
实施例3:
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草350克、红花120克、桃仁300克、制南星150克、厚朴100克、姜黄350克、桂枝200克、防己120克、当归300克、三七550克、牛膝80克、丹参350克和甘草100克混合、在40摄氏度下干燥35分钟、研磨、过800目滤筛后,获得成品制剂。
实施例4:
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草450克、红花180克、桃仁520克、制南星230克、厚朴180克、姜黄450克、桂枝300克、防己250克、当归400克、三七620克、牛膝150克、丹参450克和甘草200克混合、在45摄氏度下干燥35分钟、研磨、过1500目滤筛后,获得成品制剂。
实施例5:
一种治疗风湿骨病跌打损伤的中药组合物的制备方法,所述方法包括如下步骤:
按照相应比例选取透骨草400克、红花160克、桃仁480克、制南星200克、厚朴150克、姜黄400克、桂枝250克、防己200克、当归350克、三七600克、牛膝120克、丹参400克和甘草150克混合、在40摄氏度下干燥20分钟、研磨、过1500目滤筛后,获得成品制剂。
使用方法:将上述成品,用鸡蛋清和匀在患处冷敷;
或者用高度白酒拌好,在创伤处加热热敷,用药粉作成膏药贴贴到创伤处。
产品为外用制剂。
本发明不局限于上述可选的实施方式,任何人在本发明的启示下都可得出其他各种形式的产品,均属于本发明的保护范围。上述具体实施方式不应理解成对本发明的保护范围的限制,本领域的普通技术人员应当理解,在不背离本发明的范围下,可对前述各实施例所记载的技术方案进行修改,或对其中部分或者全部技术特征进行等同替换,与此同时这些修改或者替换,并不会使相应的技术方案的本质脱离本发明各实施例技术方案的范围。
Claims (10)
1.一种治疗风湿骨病跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
透骨草30-50份,红花10-20份,桃仁25-60份,制南星10-25份,厚朴5-20份,姜黄30-50份,桂枝15-35份,防己8-30份,当归20-55份,三七50-70份,牛膝5-18份,丹参30-50份和甘草6-25份。
2.根据权利要求1所述的一种治疗风湿骨病跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
透骨草35-45份,红花12-18份,桃仁30-52份,制南星15-23份,厚朴10-18份,姜黄35-45份,桂枝20-30份,防己12-25份,当归30-40份,三七55-62份,牛膝8-15份,丹参35-45份和甘草10-20份。
3.根据权利要求2所述的一种治疗风湿骨病跌打损伤的中药组合物,其特征在于,所述组合物主要由以下质量份数的原料制备得到:
透骨草40份,红花16份,桃仁48份,制南星20份,厚朴15份,姜黄40份,桂枝25份,防己20份,当归35份,三七60份,牛膝12份,丹参40份和甘草15份。
4.一种如权利要求1-3任一所述的治疗风湿骨病跌打损伤的中药组合物的制备方法,其特征在于,所述方法包括如下步骤:
按照相应比例选取透骨草、红花、桃仁、制南星、厚朴、姜黄、桂枝、防己、当归、三七、牛膝、丹参和甘草混合、经干燥、研磨、过筛后,获得成品。
5.根据权利要求4所述的一种治疗风湿骨病跌打损伤的中药组合物的制备方法,其特征在于,所述成品为外用制剂。
6.根据权利要求4所述的一种治疗风湿骨病跌打损伤的中药组合物的制备方法,其特征在于,所述干燥温度为40-45摄氏度。
7.根据权利要求6所述的一种治疗风湿骨病跌打损伤的中药组合物的制备方法,其特征在于,所述干燥时长为20-35分钟。
8.根据权利要求4所述的一种治疗风湿骨病跌打损伤的中药组合物的制备方法,其特征在于,所述过800-1500目滤筛。
9.一种治疗风湿骨病跌打损伤的中药组合物的使用方法,其特征在于,采用权利要求1-3任一所述的疗风湿骨病跌打损伤的中药组合物或者采用权利要求4-8任一所述的风湿骨病跌打损伤的中药组合物的制备方法获得的成品,使用时,加入溶剂调配混匀,涂覆在患处皮肤处。
10.根据权利要求9所述的一种治疗风湿骨病跌打损伤的中药组合物的使用方法,其特征在于,所述溶剂为水、鸡蛋清和白酒中的任意一种;
所述溶剂与成品调配比例为0.3-0.6:1wt%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111322190.5A CN114010745A (zh) | 2021-11-09 | 2021-11-09 | 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111322190.5A CN114010745A (zh) | 2021-11-09 | 2021-11-09 | 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114010745A true CN114010745A (zh) | 2022-02-08 |
Family
ID=80062793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111322190.5A Pending CN114010745A (zh) | 2021-11-09 | 2021-11-09 | 治疗风湿骨病跌打损伤的中药组合物、制备和使用方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114010745A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998799A (zh) * | 2006-12-27 | 2007-07-18 | 陈玉龙 | 一种治疗骨折、跌打损伤的中药制剂 |
| CN108785421A (zh) * | 2017-05-01 | 2018-11-13 | 王晓霞 | 一种用于治疗骨折的中药配方及其制法 |
-
2021
- 2021-11-09 CN CN202111322190.5A patent/CN114010745A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100998799A (zh) * | 2006-12-27 | 2007-07-18 | 陈玉龙 | 一种治疗骨折、跌打损伤的中药制剂 |
| CN108785421A (zh) * | 2017-05-01 | 2018-11-13 | 王晓霞 | 一种用于治疗骨折的中药配方及其制法 |
Non-Patent Citations (2)
| Title |
|---|
| 罗彩文: "骨折术后活血止痛汤熏洗关节康复的护理体会", 《内蒙古中医药》, no. 10, 30 October 2015 (2015-10-30), pages 178 * |
| 马依林等: "基于频数分析法的骨伤科中成药用药规律研究", 《中国医院药学杂志》, vol. 40, no. 12, 21 December 2020 (2020-12-21), pages 1385 - 1389 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100512858C (zh) | 一种治疗心脑血管病的中药制剂 | |
| CN113876688A (zh) | 抑菌养护洗液及其制备方法 | |
| CN106668274A (zh) | 具有美容、止痛止痒的外用中药保健制剂及其制备方法 | |
| CN105288096B (zh) | 一种治疗青春痘的药物 | |
| CN117064974B (zh) | 一种用于膝骨关节炎消肿镇痛的中药组合物、中药贴膏及其制备方法 | |
| CN105232746A (zh) | 一种用于治疗胸壁挫伤、肋骨骨折的中药组合物、中药制剂及其制备方法 | |
| CN113318180A (zh) | 一种治疗跌打损伤的中药组合物及其制备方法 | |
| CN103860977B (zh) | 一种治疗皮炎的药物组合物 | |
| CN112691157A (zh) | 一种风湿类关节炎药材组合物的配方及制备方法 | |
| CN113663002A (zh) | 一种治疗尖锐湿疣的中药组合物及其制备方法 | |
| CN101244149A (zh) | 一种治疗前列腺肥大和急慢性前列腺炎的中药丸 | |
| CN100358566C (zh) | 一种治疗内科虚症的中药制剂 | |
| CN104958558A (zh) | 一种治疗烧伤的药物 | |
| CN113197985A (zh) | 一种能调理皮肤问题及皮肤软组织坏死的精油 | |
| CN105832972A (zh) | 一种制备治疗痔疮的中药组合物的方法 | |
| US11944660B1 (en) | Topical traditional Chinese medicine (TCM) composition and topical preparation for cervical disease, and preparation methods thereof | |
| CN111658748A (zh) | 用于治疗痛经的组合物、口服制剂及应用 | |
| CN104644860A (zh) | 一种治疗孕产妇炎性外痔的药物组合物及其应用 | |
| CN104288270A (zh) | 一种用于治疗血栓性静脉炎的中药组合物及其制备方法 | |
| CN116509946B (zh) | 一种治疗前列腺增生的中药复方及其制备方法 | |
| CN111084842B (zh) | 治疗肩周炎、颈椎病、腰椎间盘突出、骨性关节炎的外用中药组合物 | |
| CN110841033A (zh) | 一种防治血虚寒凝型痛经的中药保健腰带及其制备方法 | |
| CN109453336A (zh) | 一种用于治疗湿症的中药组合物 | |
| CN108686007A (zh) | 一种降血脂的中药组合物 | |
| CN121466227A (zh) | 一种中药组合物、黑膏药及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220208 |
|
| RJ01 | Rejection of invention patent application after publication |